Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effects of rubidium chloride on the course of manic-depressive illness.

Literature DB >> 349155

Effects of rubidium chloride on the course of manic-depressive illness.

Abstract

Clinical studies of the effects of rubidium ions on the course of manic-depressive illness are reported. It seems that rubidium tends to increase the length of manic phases and possibly reduces the extremes of mood. Rubidium did not seem to produce any severe side effects in the dose administered, but it has a long biological half-life and caution is still required. Some details of the CSF, RBC, saliva and plasma and urine kinetics are also reported.

Entities: Chemical

Mesh：

Substances：
Rubidium

Year: 1978 PMID： 349155 PMCID： PMC1436619 DOI： 10.1177/014107687807100507

Source DB: PubMed Journal: J R Soc Med ISSN： 0141-0768 Impact factor: 18.000

18 in total

1. Acute toxicity of cesium and rubidium compounds.

Authors: G T Johnson; T R Lewis; W D Wagner
Journal: Toxicol Appl Pharmacol Date: 1975-05 Impact factor: 4.219

2. The effects of changes in internal ionic concentrations on the electrical properties of perfused giant axons.

Authors: P F BAKER; A L HODGKIN; T I SHAW
Journal: J Physiol Date: 1962-11 Impact factor: 5.182

3. A comparison of the distribution of 42K and 86Rb in rabbit and man.

Authors: R KILPATRICK; H E RENSCHLER; D S MUNRO; G M WILSON
Journal: J Physiol Date: 1956-07-27 Impact factor: 5.182

4. Effects of rubidium in purified diets fed rats.

Authors: B L GLENDENING; D B PARRISH; W G SCHRENK
Journal: J Nutr Date: 1956-12-10 Impact factor: 4.798

5. Proceedings: Rubidium salts--toxic effects in humans and clinical effects as an antidepressant drug.

Authors: R R Fieve; H L Meltzer
Journal: Psychopharmacol Bull Date: 1974-01

6. Rubidium and lithium: evaluation as antidepressant and anti-manic agents.

Authors: I Sanghvi; S Gershon
Journal: Res Commun Chem Pathol Pharmacol Date: 1973-07

7. Rubidium: biochemical, behavioral, and metabolic studies in humans.

Authors: R R Fieve; H Meltzer; D L Dunner; M Levitt; J Mendlewicz; A Thomas
Journal: Am J Psychiatry Date: 1973-01 Impact factor: 18.112

8. Rubidium: a potential modifier of affect and behaviour.

Authors: H L Meltzer; R M Taylor; S R Platmann; R R Fieve
Journal: Nature Date: 1969-07-19 Impact factor: 49.962

9. Lithium and rubidium: a role in the affective disorders.

Authors: S R Platman
Journal: Dis Nerv Syst Date: 1971-09

10. The excretion of radiorubidium Rb86, radiopotassium, K42, and potassium, sodium, and chloride by man with and without congestive heart failure.

Authors: C T RAY; S A THREEFOOT; G E BURCH
Journal: J Lab Clin Med Date: 1955-03

7 in total

1. On the rubidium and lithium content and availability in the sub-arid south-eastern Mediterranean: potential health implications.

Authors: Fyodor S Kot
Journal: Environ Geochem Health Date: 2018-06-14 Impact factor: 4.609

Effects of rubidium chloride on the course of manic-depressive illness.

1. Acute toxicity of cesium and rubidium compounds.

2. The effects of changes in internal ionic concentrations on the electrical properties of perfused giant axons.

3. A comparison of the distribution of 42K and 86Rb in rabbit and man.

4. Effects of rubidium in purified diets fed rats.

5. Proceedings: Rubidium salts--toxic effects in humans and clinical effects as an antidepressant drug.

6. Rubidium and lithium: evaluation as antidepressant and anti-manic agents.

7. Rubidium: biochemical, behavioral, and metabolic studies in humans.

8. Rubidium: a potential modifier of affect and behaviour.

9. Lithium and rubidium: a role in the affective disorders.

10. The excretion of radiorubidium Rb86, radiopotassium, K42, and potassium, sodium, and chloride by man with and without congestive heart failure.

1. On the rubidium and lithium content and availability in the sub-arid south-eastern Mediterranean: potential health implications.

2. Electrolyte metabolism in patients with periodic affective disorders during treatment with rubidium.

Review 3. Lithium, membranes, and manic-depressive illness.

4. Urinary dicarboxylic acids in patients receiving lithium or rubidium salts.

5. Possible mechanism of rubidium-induced hyperactivity in the rat.

6. Nerve fibre refractory period in patients treated with rubidium and lithium.

7. Rubidium chloride modulated the fecal microbiota community in mice.